What is Required in Order to Get the Authorities to Approve a New Contrast Medium?

Part of the Medical Radiology book series (MEDRAD)


The evaluation of diagnostic agents is governed by the same regulatory rules and principles as those for other medicinal products. This chapter summaries relevant sections of the Guideline on Clinical Evaluation of Diagnostic Agents issued by the EMEA (2010). The requirements for authorization for completely new contrast agents may differ from those for contrast agents similar to contrast agents which have already been approved.


Contrast Agent Diagnostic Performance Medicinal Product Marketing Authorization Gadopentetate Dimeglumine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. EMEA (2010) The guideline on clinical evaluation of diagnostic agents. EMEA.Doc. Ref. CHMP/EWP/1119/98/Rev.1. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003580.pdf. Accessed 1 Feb 2010

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.Danish Health and Medicines Authority (DHMA)Department of Drug Safety Surveillance and Medical DevicesKøbenhavn SDenmark

Personalised recommendations